[1]
Amtul Mussawar Sami 2023. Intravitreal Bevacizumab (Avastin) for Primary Treatment of Diffuse Diabetic Macular Oedema. Esculapio Journal of SIMS. 5, 2 (Aug. 2023), 5–8.